Compounded semaglutide is made by pharmacies for personal needs
Riveau G et al
Patients should be counseled to promptly report symptoms such as right upper quadrant pain, fever, jaundice, or severe abdominal pain with distension
[1][2] Why CVS Caremark Chose Wegovy Novo Nordisk deal: CVS Caremark negotiated preferred pricing for Wegovy, making it their primary GLP-1 option Zepbound removed: Eli Lilly's Zepbound was dropped from CVS Caremark formularies in July 2025 Cardiovascular benefit: Wegovy is the only GLP-1 FDA-approved for both weight loss AND cardiovascular risk reduction What This Means for Aetna Members Standard Aetna plans: Wegovy is covered with prior authorization Self-funded employer plans: May have different formulariescheck with HR Medicare Advantage: Coverage varies by plansee Medicare guide For more details on how CVS Caremark affects GLP-1 coverage across all insurers: Complete CVS Caremark Guide Now that you understand why Wegovy is preferred, here's what you need for prior authorization approval
Among the brand options, Wegovy is FDA-approved for chronic weight management, while Ozempic is FDA-approved to treat type 2 diabetes and is sometimes used off-label for weight loss under a physicians care
Liraglutide (1 M) did not increase the mRNA expression of inflammatory cytokines (TNF- , IL-6 and IL-1 ) or chemokines (MCP-1, CINC-1 and CX3CL1
